Article Details
Retrieved on: 2021-09-06 07:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
F. Hoffmann-La Roche Ltd.'s Alecensa (alectinib) was authorized by the China National Drug Administration (CNDA) in August 2018 for the therapy of ...
Article found on: eudaemoniablog.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here